Matching Adherence Interventions to Patient Determinants Using the Theoretical Domains Framework

Por Allemann, Samuel S., Nieuwlaat, Robby, van den Bemt, Bart J. F., Hersberger, Kurt E., Arnet, Isabelle
Publicado no Front Pharmacol (2016)

Disentangling Rheumatoid Arthritis Patients’ Implicit and Explicit Attitudes toward Methotrexate

Por Linn, Annemiek J., Vandeberg, Lisa, Wennekers, Annemarie M., Vervloet, Marcia, van Dijk, Liset, van den Bemt, Bart J. F.
Publicado no Front Pharmacol (2016)

Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists

Por Timmers, Lonneke, Boons, Christel C. L. M., Verbrugghe, Mathieu, van den Bemt, Bart J. F., Van Hecke, Ann, Hugtenburg, Jacqueline G.
Publicado no BMC Cancer (2017)

Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case–control study

Por Nielen, Johannes T.H., de Vries, Frank, Dagnelie, Pieter C., van den Bemt, Bart J.F., Emans, Pieter J., Lalmohamed, Arief, de Boer, Anthonius, Boonen, Annelies
Publicado no Br J Clin Pharmacol (2015)

Severity of Diabetes Mellitus and Total Hip or Knee Replacement: A Population-Based Case–Control Study

Por Nielen, Johannes T.H., Emans, Pieter J., Dagnelie, Pieter C., Boonen, Annelies, Lalmohamed, Arief, de Boer, Anthonius, van den Bemt, Bart J.F., de Vries, Frank
Publicado no Medicine (Baltimore) (2016)

The effect of electronic monitoring feedback on medication adherence and clinical outcomes: A systematic review

Por van Heuckelum, Milou, van den Ende, Cornelia H. M., Houterman, Anne E. J., Heemskerk, Charlotte P. M., van Dulmen, Sandra, van den Bemt, Bart J. F.
Publicado no PLoS One (2017)

Identification of antithrombotic drugs related to total joint replacement using anonymised free-text notes: a search strategy in the Clinical Practice Research Datalink

Por Nielen, Johannes TH, van den Bemt, Bart J F, Boonen, Annelies, Dagnelie, Pieter C, Emans, Pieter J, Veldhorst, Nicole, Lalmohamed, Arief, van Staa, Tjeerd-Pieter, de Vries, Frank
Publicado no BMJ Open (2015)

Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial

Por den Broeder, Alfons A., Verhoef, Lise M., Fransen, Jaap, Thurlings, Rogier, van den Bemt, Bart J. F., Teerenstra, Steven, Boers, Nadine, den Broeder, Nathan, van den Hoogen, Frank H. J.
Publicado no Trials (2017)

Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease

Por Pasma, Annelieke, Schenk, Charlotte V., Timman, Reinier, Busschbach, Jan J. V., van den Bemt, Bart J.F., Molenaar, Esmeralda, van der Laan, Willemijn H., Schrauwen, Saskia, van’t Spijker, Adriaan, Hazes, Johanna M. W.
Publicado no Arthritis Res Ther (2015)

The combined use of disease activity and infliximab serum trough concentrations for early prediction of (non-)response to infliximab in rheumatoid arthritis

Por van den Bemt, Bart J F, den Broeder, Alfons A, Wolbink, Gert-Jan, van den Maas, Aatke, Hekster, Yechiel A, van Riel, Piet L C M, Benraad, H Bart, van den Hoogen, Frank H J
Publicado em 2013

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiori...

Por van Herwaarden, Noortje, van der Maas, Aatke, Minten, Michiel J M, van den Hoogen, Frank H J, Kievit, Wietske, van Vollenhoven, Ronald F, Bijlsma, Johannes W J, van den Bemt, Bart J F, den Broeder, Alfons A
Publicado no BMJ (2015)